CXCL12 and pancreatic neoplasm: Pancreatic cancer cells (Panc1 and MiaPaCa) were briefly treated with CXCL12 (5–30 min), and activation of FAK, Akt, and ERK was examined by immunoprobing of total protein with phospho-form-specific antibodies.